Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2554 of 6351
-
New scan may improve cancer detection for men with inherited risk
Diagnosis Recruiting nowThe aim of the study is to determine if PET-CT imaging (using contrast recommended in clinical guidelines) is superior to combined bone scan and MRI/CT of the abdomen \& pelvis in detecting the increased incidence of metastasis (nodal/distant outside the pelvis) in men with prost…
Sponsor: Institute of Cancer Research, United Kingdom • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New drug shows promise for heart muscle disease symptoms
Symptom relief CompletedHypertrophic cardiomyopathy (HCM) is the most frequent genetic cardiac disease characterized by an asymmetric hypertrophic. In two third of patients, an obstruction to blood ejection is observed within the left ventricle which is named left ventricular outflow tract obstruction (…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New knee implant could last longer without cement
Disease control OngoingThe optimal method of total knee replacement component fixation to the bone remains a challenge. The use of bone cement is considered the gold standard and is the preferred technique for most surgeons. However, uncemented fixation methods have been developed in an attempt to tack…
Sponsor: Region Skane • Aim: Disease control
Last updated Jun 26, 2026 13:58 UTC
-
Leukemia treatment showdown: which works best?
Knowledge-focused OngoingThe registry aims to compare the two first-line available treatment approaches in non-high-risk APL patients aged ≤ 70 years - ATRA plus chemotherapy and ATRA plus ATO - in terms of practitioner's choice between the two options, clinical effectiveness and cost-effectiveness, long…
Sponsor: Groupe Francophone des Myelodysplasies • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Real-World study tests safety of new heart stents
Disease control OngoingThe purpose of this study is to evaluate the relative effectiveness and safety of Onyx stent compared to other (drug eluting stents) DES.
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
A million cancer Patients' genetic data could unlock better treatments
Knowledge-focused By invitation onlyTo prospectively evaluate the utility of genomic expression data and whole slide digital pathology image data as a tool to better characterize the tumors of individual patients, and to understand how genomic and histologic information from individual patients undergoing routine c…
Sponsor: GenomeDx Biosciences Corp • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
New device may predict kidney recovery in ICU patients
Diagnosis CompletedPatients with septic shock in the intensive care unit have an elevated risk of developing acute kidney injury (AKI).
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Could HIV drugs tame a rare immune disease in kids?
Disease control CompletedThe purpose of this study is to determine if treatment with reverse transcriptase inhibitors returns the interferon signature observed in patients with AGS to normal levels.
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 13:51 UTC
-
1,000 patients to be studied for 2 years after bariatric surgery
Knowledge-focused Recruiting nowThe Bialystok Bariatric Surgery Study (BBSS) is a prospective observational cohort study of patients undergoing bariatric surgery at the First Clinical Department of General and Endocrine Surgery at the Medical University of Bialystok. The BBSS consists of a battery of baseline t…
Sponsor: Medical University of Bialystok • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Nasal whooping cough vaccine gets a boost: higher dose tested in adults
Vaccine CompletedThis study evaluates the safety and immunogenicity of a higher dose formulation of a new live attenuated vaccine, BPZE1, intended to prevent Bordetella pertussis nasopharyngeal colonization and pertussis disease, and investigates whether higher doses of BPZE1 induce the live vacc…
Phase 1 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Vaccine
Last updated Jun 27, 2026 09:08 UTC
-
New knee implant aims to improve mobility for arthritis patients
Disease control OngoingThe purpose of this study is to evaluate the safety and effectiveness of the JOURNEY™ II CR Total Knee System in subjects with degenerative joint disease (DJD) requiring primary total knee replacement.
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Play therapy may boost social skills in infants with tuberous sclerosis — a trial puts it to the test
Symptom relief CompletedThe investigators are running an intervention study for young children with Tuberous Sclerosis Complex (TSC). The study will include free play-based behavioral intervention that may improve social and communication skills in children with TSC. Eligible families will have a child …
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Experimental hepatitis b drug shows promise in early trial
Disease control Stopped earlyPatients with chronic HBV infection will receive either ARC-520 or placebo in combination with entecavir or tenofovir, and be evaluated for safety and efficacy.
Phase 2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Leg movement may predict heart risk in seniors
Diagnosis OngoingBrief Summary: Current U.S. Veteran demographics reveal an aging population with significant cardiovascular dysfunction. This ultimately manifests as mobility limitation, inactivity, and a subsequent worsening of cardiovascular disease (CVD) that often leads to death. However, d…
Sponsor: VA Office of Research and Development • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Targeted drug shows promise for rare ROS1 cancers
Disease control OngoingThis phase II MATCH treatment trial identifies the effects of crizotinib in patients whose cancer has a genetic change called ROS1 translocation. Crizotinib may block a protein called ROS1, which may be needed for cancer cell growth. Researchers hope to learn if crizotinib will s…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Simple senior health quiz may predict chemo dangers
Knowledge-focused OngoingThis randomized clinical trial studies a geriatric assessment intervention in predicting chemotherapy toxicity and vulnerabilities (or weakness) in older patients with cancer. Assessing patients' functional status, comorbidities, psychological state, social support, nutritional s…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Can an epidural pump beat IV painkillers after liver surgery?
Symptom relief OngoingThe purpose of this study is to learn whether patient-controlled epidural analgesia (PCEA) is a better method for managing pain after liver resection compared to patient-controlled analgesia (IV PCA). Currently, the standard pain control method for liver resection patients is IV …
Phase 3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
What happens after cardiac arrest? new study tracks survivors for years
Knowledge-focused CompletedEarly prognosis of cardiac arrest - nearly 40000 new cases per year in France - has been extensively studied, highlighting a poor outcome (less than 8% at hospital discharge). However, little is known on mid and long-term prognostic factors and how these patients do survive from …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New Lung-Box device could save more transplant organs
Disease control CompletedThis is a safety study to compare the safety of receiving a lung treated with the Toronto EVLP System™ by SPONSOR in SPONSOR's dedicated facility against standard lung transplantation.
Sponsor: Lung Bioengineering Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New cancer drug ASTX660 tested in patients with no other options
Disease control OngoingThis is an open-label, dose-escalation Phase 1/2 study to assess the safety of ASTX660, determine the maximum tolerated dose (MTD), recommended Phase 2 dose (RP2D), and recommended dosing regimen, and to obtain preliminary efficacy, pharmacokinetic (PK), and target engagement dat…
Phase 1/2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC